Infections After Kidney Transplantation
Elmi Muller
Faculty of Medicine and Health Science & Dept of Surgery Stellenbosch University
Search for more papers by this authorElmi Muller
Faculty of Medicine and Health Science & Dept of Surgery Stellenbosch University
Search for more papers by this authorJonathan C. Craig MBChB, DipCH, MMed(Clin Epi), PhD, FAHMS
Matthew Flinders Distinguished Professor Vice President and Executive Dean
College of Medicine and Public Health, Flinders University, Adelaide, Australia
Search for more papers by this authorDonald A. Molony MD
Professor of Medicine Distinguished Teaching Professor of the University of Texas System
Division of Renal Diseases and Hypertension AND Center for Clinical Research and Evidence-based Medicine, McGovern Medical School University of Texas, Houston, TX, USA
Search for more papers by this authorGiovanni F.M. Strippoli MD, PhD, MPH, MM (Epi)
Professor of Nephrology Adjunct Professor of Epidemiology
Department of Emergency and Organ Transplantation – University of Bari, Bari, Italy
School of Public Health, University of Sydney, Sydney, NSW, Australia
Search for more papers by this authorSummary
Kidney transplantation requires significant immunosuppression to maximize graft outcomes and reduce the risk of rejection. Infection post-transplantation can be either routine infections, as experienced by no immunosuppressed patients, or true opportunistic infections, mostly experienced by immunocompromised patients. The lack of a valid standard approach for defining sepsis makes it difficult to determine the true incidence of community-acquired infection and sepsis. Hospital-acquired infection is present at hospital admission or within 48 hours after admission in patients. Most studies reporting opportunistic infection lack a formal definition of this term and when present, heterogeneity between studies was noted with regard to the types of infections considered or reported as opportunistic. Influenza is usually a community-acquired infection. Donor-derived infections are important as they might give more severe and serious complications in recipients. This chapter presents a summary of resistance rates that are reported in the literature for common gram negative bacteria.
References
- Tsertsvadze , A. et al. ( 2016 ). Community-onset sepsis and its public health burden: a systematic review . Syst. Rev. 5 : 81 .
- Cardoso , T. et al. ( 2015 ). Microbiology of healthcare-associated infections and the definition accuracy to predict infection by potentially drug resistant pathogens: a systematic review . BMC Infect. Dis. 15 : 565 .
- Winthrop , K.L. et al. ( 2015 ). Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance . Ann. Rheum. Dis. 74 ( 12 ): 2107 – 2116 .
- Bosaeed , M. and Kumar , D. ( 2018 ). Seasonal influenza vaccine in immunocompromised persons . Human Vaccine Immunother. 14 ( 6 ): 1311 – 1322 .
- Paulsen , G. and Danziger-Isakov , L. ( 2018 ). Pediatric donor disease transmission: all risks may not be created equal . Pediatr. Transplant. 22 ( 1 ): e13071 .
- Darrigo , L.G. Jr. , de Sant'Anna Carvalho , A.M. , and Machado , C.M. ( 2018 ). Chikungunya, dengue, and zika in immunocompromised hosts . Curr. Infect. Dis. Rep. 20 ( 4 ): 5 .
- Wilmes , D. et al. ( 2018 ). Bacterial pneumonia in kidney transplant recipients . Respir. Med. 137 : 89 – 94 .
- Cilloniz , C. et al. ( 2016 ). Community-acquired pneumonia related to intracellular pathogens . Intensive Care Med. 42 ( 9 ): 1374 – 1386 .
- Lubbert , C. ( 2016 ). Antimicrobial therapy of acute diarrhoea: a clinical review . Expert Rev. Anti Infect. Ther. 14 ( 2 ): 193 – 206 .
- Gajurel , K. , Dhakal , R. , and Deresinski , S. ( 2017 ). Histoplasmosis in transplant recipients . Clin. Transplant. 31 ( 10 ): e13087 .
- Gajurel , K. , Dhakal , R. , and Deresinski , S. ( 2018 ). Diagnosis and treatment of histoplasmosis in solid organ transplant patients . Curr. Opin. Infect. Dis. 31 ( 4 ): 301 – 308 .
- Kusne , S. et al. ( 2016 ). Coccidioidomycosis transmission through organ transplantation: a report of the OPTN ad hoc disease transmission advisory committee . Am. J. Transplant. 16 ( 12 ): 3562 – 3567 .
- Lee , P.P. and Lau , Y.L. ( 2017 ). Cellular and molecular defects underlying invasive fungal infections-revelations from endemic mycoses . Front. Immunol. 8 : 735 .
- Lemonovich , T.L. ( 2018 ). Mold infections in solid organ transplant recipients . Infect. Dis. Clin. North Am. 32 ( 3 ): 687 – 701 .
- Epstein , D.J. and Subramanian , A.K. ( 2018 ). Prevention and management of tuberculosis in solid organ transplant recipients . Infect. Dis. Clin. North Am. 32 ( 3 ): 703 – 718 .
- Wong , D.D. et al. ( 2018 ). Systematic review of ganciclovir pharmacodynamics during the prevention of cytomegalovirus infection in adult solid organ transplant recipients . Rev. Med. Virol. : ( 2 ): e2023 .
- Navarro , D. et al. ( 2019 ). Going beyond serology for stratifying the risk of CMV infection in transplant recipients . Rev. Med. Virol. 29 ( 1 ): e2017 .
- Kotton , C.N. ( 2010 ). Management of cytomegalovirus infection in solid organ transplantation . Nat. Rev. Nephrol. 6 ( 12 ): 711 – 721 .
- Kotton , C.N. et al. ( 2018 ). The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation . Transplantation 102 ( 6 ): 900 – 931 .
- Fischer , S.A. ( 2019 ). Is this organ donor safe?: Donor-derived infections in solid organ transplantation . Surg. Clin. North Am. 99 ( 1 ): 117 – 128 .
- Legrand , M. et al. ( 2012 ). Survival in neutropenic patients with severe sepsis or septic shock . Crit. Care Med. 40 ( 1 ): 43 – 49 .
- Blennow , O. and Ljungman , P. ( 2016 ). The challenge of antibiotic resistance in haematology patients . Br. J. Haematol. 172 ( 4 ): 497 – 511 .
- Bamoulid , J. et al. ( 2017 ). Antithymocyte globulins in renal transplantation-from lymphocyte depletion to lymphocyte activation: the doubled-edged sword . Transplant. Rev. (Orlando) 31 ( 3 ): 180 – 187 .
- Bamoulid , J. et al. ( 2017 ). Anti-thymocyte globulins in kidney transplantation: focus on current indications and long-term immunological side effects . Nephrol. Dial. Transplant. 32 ( 10 ): 1601 – 1608 .
- Gibson , S.E.R. , Harrison , J. , and Cox , J.A.G. ( 2018 ). Modelling a silent epidemic: a review of the in vitro models of latent tuberculosis . Pathogens 7 ( 4 ): 88 .
- Freifeld , A.G. et al. ( 2011 ). Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America . Clin. Infect. Dis. 52 ( 4 ): e56 – e93 .
- Trecarichi , E.M. et al. ( 2015 ). Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey . Clin. Microbiol. Infect. 21 ( 4 ): 337 – 343 .
- Prabhash , K. et al. ( 2010 ). Blood stream infections in cancer patients: a single center experience of isolates and sensitivity pattern . Indian J. Cancer 47 ( 2 ): 184 – 188 .
- Sood , S. and Gupta , R. ( 2012 ). Antibiotic resistance pattern of community acquired uropathogens at a tertiary care hospital in Jaipur, Rajasthan . Indian J. Community Med. 37 ( 1 ): 39 – 44 .
- Gillet , J.P. et al. ( 2012 ). Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma . Clin. Cancer Res. 18 ( 11 ): 3197 – 1206 .
- Metan , G. ( 2013 ). The interaction between piperacillin-tazobactam and Aspergillus galactomannan antigenemia assay: is the story over? Infection 41 ( 1 ): 293 – 294 .
- Metan , G. et al. ( 2013 ). Factors influencing the early mortality in haematological malignancy patients with nosocomial Gram negative bacilli bacteraemia: a retrospective analysis of 154 cases . Braz. J. Infect. Dis. 17 ( 2 ): 143 – 149 .
- Miedema , K.G. et al. ( 2013 ). Bacteria causing bacteremia in pediatric cancer patients presenting with febrile neutropenia–species distribution and susceptibility patterns . Support Care Cancer 21 ( 9 ): 2417 – 2426 .